Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 193

Similar articles for PubMed (Select 12450705)

1.

The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI).

Bonhoeffer J, Kohl K, Chen R, Duclos P, Heijbel H, Heininger U, Jefferson T, Loupi E.

Vaccine. 2002 Dec 13;21(3-4):298-302.

PMID:
12450705
2.

The development of standardized case definitions and guidelines for adverse events following immunization.

Kohl KS, Gidudu J, Bonhoeffer J, Braun MM, Buettcher M, Chen RT, Drammeh B, Duclos P, Heijbel H, Heininger U, Hummelman E, Jefferson T, Keller-Stanislawski B, Loupi E, Marcy SM.

Vaccine. 2007 Aug 1;25(31):5671-4. Epub 2007 Mar 12. No abstract available.

PMID:
17400339
3.

Applicability, reliability, sensitivity, and specificity of six Brighton Collaboration standardized case definitions for adverse events following immunization.

Kohl KS, Magnus M, Ball R, Halsey N, Shadomy S, Farley TA.

Vaccine. 2008 Nov 25;26(50):6349-60. doi: 10.1016/j.vaccine.2008.09.002. Epub 2008 Sep 19.

PMID:
18805456
4.

Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study.

Gold MS, Gidudu J, Erlewyn-Lajeunesse M, Law B; Brighton Collaboration Working Group on Anaphylaxis.

Vaccine. 2010 Jun 17;28(28):4487-98. doi: 10.1016/j.vaccine.2010.04.041. Epub 2010 Apr 29.

PMID:
20434547
5.

Reporting of vaccine safety data in publications: systematic review.

Bonhoeffer J, Zumbrunn B, Heininger U.

Pharmacoepidemiol Drug Saf. 2005 Feb;14(2):101-6. Review.

PMID:
15386705
6.

Safety reporting in developing country vaccine clinical trials-a systematic review.

Muehlhans S, Richard G, Ali M, Codarini G, Elemuwa C, Khamesipour A, Maurer W, Mworozi E, Kochhar S, Rundblad G, Vuitton D, Rath B.

Vaccine. 2012 May 9;30(22):3255-65. doi: 10.1016/j.vaccine.2012.02.059. Epub 2012 Mar 7. Review.

PMID:
22406279
7.

Vaccinovigilance in Europe--need for timeliness, standardization and resources.

Lankinen KS, Pastila S, Kilpi T, Nohynek H, Mäkelä PH, Olin P.

Bull World Health Organ. 2004 Nov;82(11):828-35. Epub 2004 Dec 14.

8.

Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.

LaRussa PS, Edwards KM, Dekker CL, Klein NP, Halsey NA, Marchant C, Baxter R, Engler RJ, Kissner J, Slade BA.

Pediatrics. 2011 May;127 Suppl 1:S65-73. doi: 10.1542/peds.2010-1722J. Epub 2011 Apr 18.

9.

Combination vaccines: postlicensure safety evaluation.

Chen RT, Pool V, Takahashi H, Weniger BG, Patel B.

Clin Infect Dis. 2001 Dec 15;33 Suppl 4:S327-33. Review.

10.

Allergic reactions to Japanese encephalitis vaccine.

Plesner AM.

Immunol Allergy Clin North Am. 2003 Nov;23(4):665-97. Review. Erratum in: Immunol Allergy Clin North Am. 2004 May;24(2):335.

PMID:
14753386
11.

[Surveillance system for adverse events following immunization against yellow fever in Burkina Faso in 2008. Good practice recommendations].

Yaméogo TM, Breugelmans JG, Kambou JL, Badolo O, Tiendrebéogo S, Traoré E, Avokey F, Yactayo S.

Med Trop (Mars). 2009 Aug;69(4):320-1. French.

PMID:
19725376
12.

Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data.

Sejvar JJ, Kohl KS, Bilynsky R, Blumberg D, Cvetkovich T, Galama J, Gidudu J, Katikaneni L, Khuri-Bulos N, Oleske J, Tapiainen T, Wiznitzer M; Brighton Collaboration Encephalitis Working Group.

Vaccine. 2007 Aug 1;25(31):5771-92. Epub 2007 May 11. No abstract available.

PMID:
17570566
13.

The Brighton Collaboration: Creating a Global Standard for Case Definitions (and Guidelines) for Adverse Events Following Immunization.

Kohl KS, Bonhoeffer J, Braun MM, Chen RT, Duclos P, Heijbel H, Heininger U, Loupi E, Marcy SM.

In: Henriksen K, Battles JB, Marks ES, Lewin DI, editors. Advances in Patient Safety: From Research to Implementation (Volume 2: Concepts and Methodology). Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Feb.

14.

Capacity for a global vaccine safety system: the perspective of national regulatory authorities.

Graham JE, Borda-Rodriguez A, Huzair F, Zinck E.

Vaccine. 2012 Jul 13;30(33):4953-9. doi: 10.1016/j.vaccine.2012.05.045. Epub 2012 May 30.

PMID:
22658930
15.

Developing a national system for dealing with adverse events following immunization.

Mehta U, Milstien JB, Duclos P, Folb PI.

Bull World Health Organ. 2000;78(2):170-7.

16.

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology.

Stroke. 2003 Aug;34(8):e109-37. Epub 2003 Jul 17. Erratum in: Stroke. 2003 Nov;34(11):2774.

17.

Surveillance of adverse effects following vaccination and safety of immunization programs.

Waldman EA, Luhm KR, Monteiro SA, Freitas FR.

Rev Saude Publica. 2011 Feb;45(1):173-84. Review. English, Portuguese.

18.

Overview of the Clinical Consult Case Review of adverse events following immunization: Clinical Immunization Safety Assessment (CISA) network 2004-2009.

Williams SE, Klein NP, Halsey N, Dekker CL, Baxter RP, Marchant CD, LaRussa PS, Sparks RC, Tokars JI, Pahud BA, Aukes L, Jakob K, Coronel S, Choi H, Slade BA, Edwards KM.

Vaccine. 2011 Sep 16;29(40):6920-7. doi: 10.1016/j.vaccine.2011.07.044. Epub 2011 Jul 27. Review.

PMID:
21801776
19.

The Vaccine Safety Datalink: a model for monitoring immunization safety.

Baggs J, Gee J, Lewis E, Fowler G, Benson P, Lieu T, Naleway A, Klein NP, Baxter R, Belongia E, Glanz J, Hambidge SJ, Jacobsen SJ, Jackson L, Nordin J, Weintraub E.

Pediatrics. 2011 May;127 Suppl 1:S45-53. doi: 10.1542/peds.2010-1722H. Epub 2011 Apr 18. Review.

20.

[Essential to monitor vaccine safety].

Heijbel H.

Lakartidningen. 2001 Sep 5;98(36):3777-8. Swedish.

PMID:
11586806
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk